Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial
scientific article published on 5 April 2016
Author/s
author: Jean-Yves Blay, Axel Le Cesne, Olivier Mir, Isabelle Ray-Coquard, Nicolas Isambert, Florence Duffaud, François Bertucci, Emmanuelle Bompas, Maud Toulmonde, Olivier Bouché, Claire Cropet, Mathieu Molimard, Philippe Alexandre Cassier, Antoine Adenis, David Pérol
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.